Cadazolid-matching placebo

DRUG2 trials

Sponsors

Actelion

Conditions

Clostridium Difficile Infection

Phase 3

Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea

CompletedNCT01983683

ActelionClostridium Difficile Infection

Start: 2013-12-12End: 2017-05-02Updated: 2025-02-04

Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea

CompletedNCT01987895

ActelionClostridium Difficile Infection

Start: 2014-03-27End: 2017-03-24Updated: 2025-02-04

Related Papers

Clostridium difficile Infection-Daily Symptoms (CDI-DaySyms™) questionnaire: psychometric characteristics and responder thresholds.

2019-05-034 citations

Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials.

2019-01-2944 citations

The CDI-DaySyms: Content Development of a New Patient-Reported Outcome Questionnaire for Symptoms of Clostridium difficile Infection.

2017-11-078 citations

The Clostridium difficile Infection – Daily Symptoms (CDI-DaySyms™) Patient-Reported Outcome (PRO) Questionnaire: Final Validation and Responder Thresholds

Open Forum Infectious Diseases2017-01-012 citations